Detecting dementia, particularly Alzheimer's disease, involves a multifaceted approach that combines clinical assessments, cognitive tests, and imaging techniques. Early signs often include memory loss, confusion, and difficulty in problem-solving or completing familiar tasks. Clinicians may utilize tools like the Mini-Mental State Examination (MMSE) or Montreal Cognitive Assessment (MoCA) to evaluate cognitive functions such as memory, attention, and language. Neuroimaging, like MRI or PET scans, helps identify brain changes such as atrophy or abnormal protein deposits characteristic of Alzheimer's. Biomarkers in cerebrospinal fluid, such as tau and amyloid-beta proteins, provide further insights into disease progression. Beyond these, behavioral and functional assessments help gauge daily life impacts. Timely detection allows for interventions like medication, cognitive therapies, and lifestyle adjustments that can improve quality of life and potentially slow disease progression.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China